Consolidated revenue increased by 29.9% to Rs 1,221.6 crore during the period under review. Of this, India revenue was Rs 977.1 crore (up 29% YoY) and Health City Cayman Islands (HCCI) revenue was Rs 244.5 crore (up 33.3% YoY).

Consolidated EBITDA improved by 57.1% to Rs 290.4 crore in Q4 FY23 from Rs 184.8 crore in Q4 FY22. EBITDA margin in Q4 FY23 was 23.8% as against 19.7% in Q4 FY22.

The company's consolidated net profit jumped 77.3% to Rs 606.6 crore on a 22.2% rise in consolidated revenue to Rs 4,524.8 crore in FY23 as compared with FY22.

As on 31 March 2023, the total borrowings less cash, bank balance and current investments was Rs 131 crore representing a net debt to equity ratio of 0.06. (Out of which, borrowings worth US$ 32 million is foreign currency denominated).

Dr. Emmanuel Rupert, managing director and group CEO, Narayana Hrudayalaya, said: “The current fiscal year exhibited robust financial performance.

We are pleased to report the highest-ever revenue and profitability in the fourth quarter, as well as for the financial year, which is attributed to increased patient footfalls along with improvements in specialty and payor mix.

The performance improvement is supported by the growth in business across our flagship units, other hospitals, and newer hospitals, in addition to the increased contribution of international patients. Our Cayman business demonstrated continued growth and contributed to the overall performance.

We are in the phase of transforming our business to offer comprehensive healthcare services by becoming more patient-oriented digitally native and operationally efficient to offer quality integrated services at an affordable cost.”

Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company has a network of 19 hospitals and 4 heart centers across India along with overseas presence at Cayman Islands, with over 5,880 operational beds and a capacity of over 6,180 beds.

On the BSE, 12,882 shares were traded in the counter so far compared with average daily volumes of 7,140 shares in the past two weeks.

The stock zoomed 8.15% in early to hit a high of Rs 835.6, which is also a 52-week high for the counter.